Oxoglutarate dehydrogenase complex
oxoglutarate dehydrogenase | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
ExPASy | NiceZyme view | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
The oxoglutarate dehydrogenase complex (OGDC) or α-ketoglutarate dehydrogenase complex is an enzyme complex, most commonly known for its role in the citric acid cycle.
Units
Much like pyruvate dehydrogenase complex (PDC), this enzyme forms a complex composed of three components:
Unit | EC number | Name | Gene | Cofactor |
E1 | EC 1.2.4.2 | oxoglutarate dehydrogenase | OGDH | thiamine pyrophosphate (TPP) |
E2 | EC 2.3.1.61 | dihydrolipoyl succinyltransferase | DLST | lipoic acid, Coenzyme A |
E3 | EC 1.8.1.4 | dihydrolipoyl dehydrogenase | DLD | FAD, NAD |
Three classes of these multienzyme complexes have been characterized: one specific for
Properties
Metabolic pathways
This enzyme participates in three different pathways:
- Citric acid cycle (KEGG link: MAP00020)
- Lysine degradation (KEGG link: MAP00310)
- Tryptophan metabolism (KEGG link: MAP00380)
Kinetic properties
The following values are from Azotobacter vinelandii (1):
- KM: 0.14 ± 0.04 mM
- Vmax : 9 ± 3 μmol.min−1.mg−1
Citric acid cycle
Reaction
The reaction catalyzed by this enzyme in the citric acid cycle is:
- NADH
This reaction proceeds in three steps:
- decarboxylation of α-ketoglutarate,
- reduction of NAD+ to NADH,
- and subsequent transfer to succinyl CoA.
Regulation
Oxoglutarate dehydrogenase is a key control point in the citric acid cycle. It is inhibited by its products,
By controlling the amount of available reducing equivalents generated by the
While an increase in flux through this pathway generates ATP for the cell, the pathway also generates
Oxoglutarate dehydrogenase is considered to be a redox sensor in the
When mitochondria are treated with excess hydrogen peroxide, flux through the electron transport chain is reduced, and NADH production is halted.[4][5] Upon consumption and removal of the free radical source, normal mitochondrial function is restored.
It is believed that the temporary inhibition of mitochondrial function stems from the reversible glutathionylation of the E2-lipoac acid domain of Oxoglutarate dehydrogenase.[5] Glutathionylation, a form of post-translational modification, occurs during times of increased concentrations of free radicals, and can be undone after hydrogen peroxide consumption via glutaredoxin.[4] Glutathionylation “protects” the lipoic acid of the E2 domain from undergoing oxidative damage, which helps spare the Oxoglutarate dehydrogenase complex from oxidative stress.
Oxoglutarate dehydrogenase activity is turned off in the presence of free radicals in order to protect the enzyme from damage. Once free radicals are consumed by the cell, the enzyme’s activity is turned back on via glutaredoxin. The reduction in activity of the enzyme under times of oxidative stress also serves to slow the flux through the electron transport chain, which slows production of free radicals.
In addition to free radicals and the mitochondrial redox state, Oxoglutarate dehydrogenase activity is also regulated by ATP/ADP ratios, the ratio of Succinyl-CoA to CoA-SH, and the concentrations of various metal ion cofactors (Mg2+, Ca2+).
Stress response
Oxoglutarate dehydrogenase plays a role in the cellular response to stress. The enzyme complex undergoes a stress-mediated temporary inhibition upon acute exposure to stress. The temporary inhibition period sparks a stronger up-regulation response, allowing an increased level of oxoglutarate dehydrogenase activity to compensate for the acute stress exposure.[8] Acute exposures to stress are usually at lower, tolerable levels for the cell.
Pathophysiologies can arise when the stress becomes cumulative or develops into chronic stress. The up-regulation response that occurs after acute exposure can become exhausted if the inhibition of the enzyme complex becomes too strong.
Pathology
2-Oxo-glutarate dehydrogenase is an
Activity of the 2-oxoglutarate dehydrogenase complex is decreased in many neurodegenerative diseases.
In the metabolic disease combined malonic and methylmalonic aciduria (CMAMMA) due to ACSF3 deficiency, mitochondrial fatty acid synthesis (mtFASII) is impaired, which is the precursor reaction of lipoic acid biosynthesis.[13][14] The result is a reduced lipoylation degree of important mitochondrial enzymes, such as oxoglutarate dehydrogenase complex (OGDC).[14]
References
Further reading
- Bunik V, Westphal AH, de Kok A (June 2000). "Kinetic properties of the 2-oxoglutarate dehydrogenase complex from Azotobacter vinelandii evidence for the formation of a precatalytic complex with 2-oxoglutarate". European Journal of Biochemistry. 267 (12): 3583–91. PMID 10848975.
- Bunik VI, Strumilo S (2009). "Regulation of Catalysis Within Cellular Network: Metabolic and Signaling Implications of the 2-Oxoglutarate Oxidative Decarboxylation". Current Chemical Biology. 3 (3): 279–290. .
- Bunik VI, Fernie AR (August 2009). "Metabolic control exerted by the 2-oxoglutarate dehydrogenase reaction: a cross-kingdom comparison of the crossroad between energy production and nitrogen assimilation". The Biochemical Journal. 422 (3): 405–21. PMID 19698086.
- Trofimova L, Lovat M, Groznaya A, Efimova E, Dunaeva T, Maslova M, et al. (October 2010). "Behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases". International Journal of Alzheimer's Disease. 2010: 749061. PMID 21049004.
External links
- Oxoglutarate+dehydrogenase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)